A casein hydrolysate based formulation attenuates obesity and associated nonalcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice

PLoS ONE

Volumn 12, Issue 7, 2017, Pages

  Schoemaker, Marieke H ^a   Kleemann, Robert ^b   Morrison, Martine C ^b   Verheij, Joanne ^c   Salic, Kanita ^b   Van Tol, Eric A F ^a   Kooistra, Teake ^b   Wielinga, Peter Y ^b  

^a Mead Johnson Nutrition   (Netherlands)

^b Netherlands Organization for Scientific Research   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CASEIN HYDROLYSATE; CHOLESTEROL; COLLAGEN; DOCOSAHEXAENOIC ACID; INSULIN; LEPTIN; NUTRITION SUPPLEMENT; SERUM AMYLOID A; TRIACYLGLYCEROL; CASEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; FOLLOW UP; FOOD INTAKE; HORMONE BLOOD LEVEL; INFLAMMATION; INSULIN BLOOD LEVEL; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; LIPID DIET; LIVER LEVEL; LOBULAR INFLAMMATION; LOW FAT DIET; MACROVESICULAR STEATOSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; STEATOSIS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ANIMAL; DRUG EFFECTS; GENETICS; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY; WEIGHT GAIN;

ADIPOSITY; ANIMALS; ATHEROSCLEROSIS; CASEINS; DIET, HIGH-FAT; MALE; MICE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RECEPTORS, LDL; WEIGHT GAIN;

EID: 85021931638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0180648     Document Type: Article

References (51)

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384(9945):766-81. Epub 2014/06/02.https://doi.org/10.1016/S0140-6736(14)60460-8 PMID: 24880830
2. Yates T, Davies MJ, Khunti K. Obesity and chronic disease in younger people: an unfolding crisis. The British journal of general practice: the journal of the Royal College of General Practitioners. 2012; 62 (594):4-5. Epub 2012/04/24.
3. Dietz WH. Critical periods in childhood for the development of obesity. The American journal of clinical nutrition. 1994; 59(5):955-9. Epub 1994/05/01. PMID: 8172099
4. Astrup A, Brand-Miller J. Diet composition and obesity. Lancet. 2012; 379(9821):1100; author reply -1.Epub 2012/03/27.
5. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nature reviews Endocrinology. 2011; 7(11):639-46. Epub 2011/08/10. https://doi.org/10.1038/nrendo.2011.126 PMID: 21826100
6. Luke A, Cooper RS. Physical activity does not influence obesity risk: time to clarify the public health message. International journal of epidemiology. 2013; 42(6):1831-6. Epub 2014/01/15. https://doi.org/10.1093/ije/dyt159 PMID: 24415616
7. Prentice A, Jebb S. Energy intake/physical activity interactions in the homeostasis of body weight regulation.Nutrition reviews. 2004; 62(7 Pt 2):S98-104. Epub 2004/09/25. PMID: 15387474
8. van der Heijden RA, Sheedfar F, Morrison MC, Hommelberg PP, Kor D, Kloosterhuis NJ, et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice. Aging. 2015; 7(4):256-68. Epub 2015/05/17. https://doi.org/10.18632/aging.100738 PMID: 25979814
9. Mulder P, Morrison MC, Wielinga PY, van Duyvenvoorde W, Kooistra T, Kleemann R. Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity. Int J Obes (Lond). 2015. Epub 2015/10/27.
10. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation- mechanisms and therapeutic targets. Arteriosclerosis, thrombosis, and vascular biology. 2012; 32 (8):1771-6. Epub 2012/07/21. https://doi.org/10.1161/ATVBAHA.111.241869 PMID: 22815343
11. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends in endocrinology and metabolism: TEM. 2010; 21(4):199-205.Epub 2010/01/19. https://doi.org/10.1016/j.tem.2009.12.008 PMID: 20080045
12. von Berg A, Filipiak-Pittroff B, Kramer U, Link E, Bollrath C, Brockow I, et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). The Journal of allergy and clinical immunology. 2008; 121(6):1442-7. Epub 2008/06/10. https://doi.org/10.1016/j.jaci.2008.04.021 PMID: 18539195
13. Berni Canani R, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leone L, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. The Journal of allergy and clinical immunology. 2012; 129(2):580-2, 2 e1-5. Epub 2011/11/15. https://doi.org/10.1016/j.jaci.2011.10.004 PMID: 22078573
14. Lapillonne A, Pastor N, Zhuang W, Scalabrin DM. Infants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life.BMC pediatrics. 2014; 14:168. Epub 2014/07/06. https://doi.org/10.1186/1471-2431-14-168 PMID: 24989353
15. Drover J, Hoffman DR, Castaneda YS, Morale SE, Birch EE. Three randomized controlled trials of early long-chain polyunsaturated Fatty Acid supplementation on means-end problem solving in 9-montholds.Child development. 2009; 80(5):1376-84. Epub 2009/09/22. https://doi.org/10.1111/j.1467-8624.2009.01339.x PMID: 19765006
16. Clausen MR, Zhang X, Yde CC, Ditlev DB, Lillefosse HH, Madsen L, et al. Intake of hydrolyzed casein is associated with reduced body fat accretion and enhanced phase II metabolism in obesity prone C57BL/6J mice. PloS one. 2015; 10(3):e0118895. Epub 2015/03/05. https://doi.org/10.1371/journal.pone.0118895 PMID: 25738501
17. Lillefosse HH, Tastesen HS, Du ZY, Ditlev DB, Thorsen FA, Madsen L, et al. Hydrolyzed casein reduces diet-induced obesity in male C57BL/6J mice. The Journal of nutrition. 2013; 143(9):1367-75. Epub 2013/07/12. https://doi.org/10.3945/jn.112.170415 PMID: 23843475
18. Lambers TT, Gloerich J, van Hoffen E, Alkema W, Hondmann DH, van Tol EA. Clustering analyses in peptidomics revealed that peptide profiles of infant formulae are descriptive. Food science & nutrition.2015; 3(1):81-90. Epub 2015/02/05.
19. Flachs P, Rossmeisl M, Bryhn M, Kopecky J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin Sci (Lond). 2009; 116(1):1-16. Epub 2008/11/29.
20. Gray B, Steyn F, Davies PS, Vitetta L. Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. European journal of clinical nutrition. 2013; 67 (12):1234-42. Epub 2013/10/17. https://doi.org/10.1038/ejcn.2013.197 PMID: 24129365
21. Lopez-Alarcon M, Martinez-Coronado A, Velarde-Castro O, Rendon-Macias E, Fernandez J. Supplementation of n3 long-chain polyunsaturated fatty acid synergistically decreases insulin resistance with weight loss of obese prepubertal and pubertal children. Archives of medical research. 2011; 42(6):502. Epub 2011/12/06. https://doi.org/10.1016/j.arcmed.2011.06.010 PMID: 22136960
22. Juarez-Hernandez E, Chavez-Tapia NC, Uribe M, Barbero-Becerra VJ. Role of bioactive fatty acids in nonalcoholic fatty liver disease. Nutrition journal. 2016; 15(1):72. Epub 2016/08/04. https://doi.org/10.1186/s12937-016-0191-8 PMID: 27485440
23. Wielinga PY, Harthoorn LF, Verschuren L, Schoemaker MH, Jouni ZE, van Tol EA, et al. Arachidonic acid/docosahexaenoic acid-supplemented diet in early life reduces body weight gain, plasma lipids, and adiposity in later life in ApoE 3Leiden mice. Molecular nutrition & food research. 2012; 56(7):1081-9.Epub 2012/05/23.
24. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2010; 29(3):312-6. Epub 2009/11/10. https://doi.org/10.1016/j.clnu.2009.09.008 PMID: 19896252
25. Ritze Y, Bardos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, et al. Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PloS one. 2014; 9(1):e80169. Epub 2014/01/30. https://doi.org/10.1371/journal.pone.0080169 PMID: 24475018
26. Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, van Erk M, et al. MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circulation research. 2009; 105(1):99-107. Epub 2009/05/30. https://doi.org/10.1161/CIRCRESAHA.109.199166 PMID: 19478200
27. Liang W, Menke AL, Driessen A, Koek GH, Lindeman JH, Stoop R, et al. Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology. PloS one. 2014; 9 (12):e115922. Epub 2014/12/24. https://doi.org/10.1371/journal.pone.0115922 PMID: 25535951
28. Morrison MC, Mulder P, Salic K, Verheij J, Liang W, van Duyvenvoorde W, et al. Intervention with a caspase- 1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice. Int J Obes (Lond). 2016; 40(9):1416-23. Epub 2016/04/29.
29. Bligh EG D W. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37 (8):911-7. https://doi.org/10.1139/o59-099 PMID: 13671378
30. Lowry OH R N, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of biological chemistry. 1951; 193(1):265-75. PMID: 14907713
31. Morrison MC, Liang W, Mulder P, Verschuren L, Pieterman E, Toet K, et al. Mirtoselect, an anthocyanin- rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE (∗) 3Leiden mice. Journal of hepatology. 2015; 62(5):1180-6. Epub 2014/12/17. https://doi.org/10.1016/j.jhep.2014.12.011 PMID: 25514555
32. Kooistra T, Verschuren L, de Vries-van der Weij J, Koenig W, Toet K, Princen HM, et al. Fenofibrate reduces atherogenesis in ApoE. 3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol. Arteriosclerosis, thrombosis, and vascular biology. 2006; 26(10):2322-30.Epub 2006/07/29. https://doi.org/10.1161/01.ATV.0000238348.05028.14 PMID: 16873727
33. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review.Journal of the American College of Nutrition. 2001; 20(1):5-19. Epub 2001/04/11. PMID: 11293467
34. Radonjic M, Wielinga PY, Wopereis S, Kelder T, Goelela VS, Verschuren L, et al. Differential effects of drug interventions and dietary lifestyle in developing type 2 diabetes and complications: a systems biology analysis in LDLr-/- mice. PloS one. 2013; 8(2):e56122. Epub 2013/03/05. https://doi.org/10.1371/journal.pone.0056122 PMID: 23457508
35. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, Princen HM, et al.Mouse models for atherosclerosis and pharmaceutical modifiers. Arteriosclerosis, thrombosis, and vascular biology. 2007; 27(8):1706-21. Epub 2007/06/02. https://doi.org/10.1161/ATVBAHA.107.142570 PMID: 17541027
36. Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. The British journal of nutrition. 2013; 109 Suppl 1:S1-34. Epub 2013/02/01.
37. Romacho T, Elsen M, Rohrborn D, Eckel J. Adipose tissue and its role in organ crosstalk. Acta Physiol (Oxf). 2014; 210(4):733-53. Epub 2014/02/06.
38. Mulder P, Morrison MC, Verschuren L, Liang W, van Bockel JH, Kooistra T, et al. Reduction of obesityassociated white adipose tissue inflammation by rosiglitazone is associated with reduced non-alcoholic fatty liver disease in LDLr-deficient mice. Scientific reports. 2016; 6:31542. Epub 2016/08/23. https://doi.org/10.1038/srep31542 PMID: 27545964
39. Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators of inflammation. 2010; 2010. Epub 2010/08/14.
40. Poitou C, Coussieu C, Rouault C, Coupaye M, Cancello R, Bedel JF, et al. Serum amyloid A: a marker of adiposity-induced low-grade inflammation but not of metabolic status. Obesity (Silver Spring). 2006; 14(2):309-18. Epub 2006/03/31.
41. Kleemann R, Verschuren L, van Erk MJ, Nikolsky Y, Cnubben NH, Verheij ER, et al. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis. Genome biology. 2007; 8(9):R200. Epub 2007/09/26. https://doi.org/10.1186/gb-2007-8-9-r200 PMID: 17892536
42. Krishack PA, Bhanvadia CV, Lukens J, Sontag TJ, De Beer MC, Getz GS, et al. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. Journal of the American Heart Association. 2015; 4(7).Epub 2015/07/19.
43. Fuijkschot WW, Morrison MC, van der Linden R, Krijnen PA, Zethof IP, Theyse LF, et al. Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/- mice. Atherosclerosis.2016; 255:164-70. Epub 2016/11/09. https://doi.org/10.1016/j.atherosclerosis.2016.07.909 PMID: 27825629
44. RajalaMWS P. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003; 144(9):3765-73. https://doi.org/10.1210/en.2003-0580 PMID: 12933646
45. Mulder P, van den Hoek AM, Kleemann R. The CCR2 Inhibitor Propagermanium Attenuates Diet- Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis. PloS one.2017; 12(1):e0169740. Epub 2017/01/12. https://doi.org/10.1371/journal.pone.0169740 PMID: 28076416
46. Brumbaugh DE, Friedman JE. Developmental origins of nonalcoholic fatty liver disease. Pediatric research. 2014; 75(1-2):140-7. Epub 2013/11/07. https://doi.org/10.1038/pr.2013.193 PMID: 24192698
47. Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. The ISME journal. 2015. Epub 2015/09/24.
48. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflammatory bowel diseases.2010; 16(4):684-95. Epub 2009/09/24. https://doi.org/10.1002/ibd.21108 PMID: 19774643
49. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity.Nature reviews Endocrinology. 2015; 11(10):577-91. Epub 2015/08/12. https://doi.org/10.1038/nrendo.2015.128 PMID: 26260141
50. Arnoldussen IA, Wiesmann M, Pelgrim CE, Wielemaker EM, van Duyvenvoorde W, Amaral-Santos PL, et al. Butyrate restores HFD-induced adaptations in brain function and metabolism in mid-adult obese mice. Int J Obes (Lond). 2017. Epub 2017/02/22.
51. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. Journal of hepatology. 2013; 58(6):1218-29. Epub 2012/12/15. https://doi.org/10.1016/j.jhep.2012.12.003 PMID: 23238106